Perdue Kidd & Vickery Files Lawsuit Against Abbott Laboratories for...
DALLAS July 29 2011 PRNewswire Humira defect lawyers filed a lawsuit against Abbott Laboratories in Texas state court claiming Abbott's blockbuster drug Humira caused a lifethreatening disease...
View ArticleTiGenix to participate and present at key investor and business development...
PRESS RELEASE TiGenix to participate and present at key investor and business development meetings Leuven BELGIUM September 28 2017 0700h CET TiGenix NV Euronext Brussels and NASDAQ TIG an advanced...
View ArticleProvention Bio Inc. Completes its Executive Management Team
LEBANON N.J. Sept. 28 2017 PRNewswire Provention Bio Inc. a clinicalstage biopharmaceutical company dedicated to sourcing developing and commercializing novel therapeutics aimed at intercepting and...
View ArticleNektar Therapeutics Reports Second Quarter 2011 Financial Results
SAN FRANCISCO Aug. 4 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the second quarter ended June 30 2011. Cash cash equivalents and investments at June 30...
View ArticleTakeda and SGC Announce a Collaboration Agreement Using Patient TissueBased...
Takeda Pharmaceutical Company Limited Takeda TSE 4502 Karolinska Institutet KI and The Structural Genomics Consortium SGC today announced a combined precompetitive and proprietary collaboration to...
View ArticlePrometheus and the Medco Research Institute to Evaluate the Use of...
SAN DIEGO and FRANKLIN LAKES N.J. Aug. 15 2011 PRNewswire Prometheus Laboratories Inc. a specialty pharmaceutical and diagnostics company that is part of Nestle Health Science and the Medco Research...
View ArticleThe Kenneth Rainin Foundation Launches Second IBD Awards Program and...
OAKLAND Calif. Aug. 17 2011 PRNewswireUSNewswire The Kenneth Rainin Foundation KRF announced today the establishment of its Breakthrough Awards Program which is designed to enable investigators to...
View ArticleQuanterix Digital ELISA Measures Low Abundance Biomarkers of Inflammation in...
CAMBRIDGE Mass. Aug. 19 2011 PRNewswire Quanterix Corporation a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array SiMoA&8482;...
View ArticleCoronado Biosciences Files to Become a Public Reporting Company
NEW YORK July 18 2011 PRNewswire Coronado Biosciences Inc. the "Company" a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases...
View ArticleAmerican Idol Contestant Casey Abrams Launches Nationwide Contest to Raise...
HORSHAM Pa. July 25 2011 PRNewswire American Idol contestant Casey Abrams is launching a national disease awareness campaign IBD Icons to let people know that living with an inflammatory bowel disease...
View ArticleNektar to Announce Financial Results for the Second Quarter of 2011 on...
SAN FRANCISCO July 27 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR will announce its financial results for the second quarter ended June 30 2011 on Thursday August 4 2011 after the close of...
View ArticlePerdue Kidd & Vickery Files Lawsuit Against Abbott Laboratories for...
DALLAS July 29 2011 PRNewswire Humira defect lawyers filed a lawsuit against Abbott Laboratories in Texas state court claiming Abbott's blockbuster drug Humira caused a lifethreatening disease...
View ArticleTiGenix to participate and present at key investor and business development...
PRESS RELEASE TiGenix to participate and present at key investor and business development meetings Leuven BELGIUM September 28 2017 0700h CET TiGenix NV Euronext Brussels and NASDAQ TIG an advanced...
View ArticleProvention Bio Inc. Completes its Executive Management Team
LEBANON N.J. Sept. 28 2017 PRNewswire Provention Bio Inc. a clinicalstage biopharmaceutical company dedicated to sourcing developing and commercializing novel therapeutics aimed at intercepting and...
View ArticleNektar Therapeutics Reports Second Quarter 2011 Financial Results
SAN FRANCISCO Aug. 4 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR today reported its financial results for the second quarter ended June 30 2011. Cash cash equivalents and investments at June 30...
View ArticleTakeda and SGC Announce a Collaboration Agreement Using Patient TissueBased...
Takeda Pharmaceutical Company Limited Takeda TSE 4502 Karolinska Institutet KI and The Structural Genomics Consortium SGC today announced a combined precompetitive and proprietary collaboration to...
View ArticlePrometheus and the Medco Research Institute to Evaluate the Use of...
SAN DIEGO and FRANKLIN LAKES N.J. Aug. 15 2011 PRNewswire Prometheus Laboratories Inc. a specialty pharmaceutical and diagnostics company that is part of Nestle Health Science and the Medco Research...
View ArticleThe Kenneth Rainin Foundation Launches Second IBD Awards Program and...
OAKLAND Calif. Aug. 17 2011 PRNewswireUSNewswire The Kenneth Rainin Foundation KRF announced today the establishment of its Breakthrough Awards Program which is designed to enable investigators to...
View ArticleQuanterix Digital ELISA Measures Low Abundance Biomarkers of Inflammation in...
CAMBRIDGE Mass. Aug. 19 2011 PRNewswire Quanterix Corporation a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array SiMoA&8482;...
View ArticleAbbVie Amgen settle Humirarelated IP litigation
AbbVie Inc. and Amgen Inc. have settled litigation surrounding the latter's intellectual property related to a proposed biosimilar adalimumab named AmgevitaAmjevita. Under the settlement Amgen receives...
View Article